acetyl-l-carnitine alc and propionyl-l-carnitine plc analytical standard 20064-19-1 Acetyl-L-Carnitine
Description
Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C
doi: 10.1016/j.fbio.2020.100875
Innovation in Aging, 3(Supplement_1), S415S416
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study (NRG- GI004/SWOG-S1610): A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC)
